{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT00951210",
      "OrgStudyIdInfo": {
        "OrgStudyId": "1202-2"
      },
      "Organization": {
        "OrgFullName": "Pluristem Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)",
      "OfficialTitle": "Phase I Study of Intramuscular (IM) Injections of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia. PLX-PAD Are Mesenchymal-Like Stromal Cells Derived From a Full Term Placenta."
    },
    "StatusModule": {
      "StatusVerifiedDate": "November 2011",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "August 2009"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "January 2011",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "October 2011",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "August 3, 2009",
      "StudyFirstSubmitQCDate": "August 3, 2009",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 4, 2009",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "May 24, 2015",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "May 27, 2015",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Pluristem Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to determine the safety of PLX-PAD, Intra-muscular injections for the treatment of CLI patients."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Peripheral Artery Disease",
          "Peripheral Vascular Disease",
          "Critical Limb Ischemia"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Peripheral Artery Disease",
          "Peripheral Vascular Disease",
          "Critical limb ischemia",
          "PAD",
          "CLI"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Factorial Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "12",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "PLX-PAD low dose",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "IM injection Single treatment; multiple injections",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: PLX-PAD"
              ]
            }
          },
          {
            "ArmGroupLabel": "PLX-PAD high dose",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "IM injection Double treatment; multiple injections",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: PLX-PAD"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "PLX-PAD",
            "InterventionDescription": "IM injection",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "PLX-PAD high dose",
                "PLX-PAD low dose"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Adverse events; Amputation incidence, Death incidence & Rehospitalization incidence",
            "PrimaryOutcomeTimeFrame": "3 months"
          },
          {
            "PrimaryOutcomeMeasure": "Immunological reaction",
            "PrimaryOutcomeTimeFrame": "3 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of critical limb ischemia defined as persistent, recurring ischemic rest pain for at least two (2) weeks, and/or ulceration or gangrene of the foot or toe, with ABI < 0.6 or/and TBI < 0.4\nRutherford category 4-5\nNon candidate for revascularization or endovascular intervention based on unfavorable vascular anatomy or significant co-morbid medical conditions as confirmed by vascular study (e.g., angiogram, MRA) obtained within 3 months prior screening visit and signed approval of vascular surgeon. The decision to classify the subject as a non-candidate will be made by the investigator and confirmed by an independent third party vascular surgeon who is not participating in the study.\nIn the opinion of the investigator, major amputation is not anticipated over a period of three (3) months.\nThose diabetic subjects who are on optimal diabetes medication, with an HbA1c < 8%\n\nExclusion Criteria:\n\nUncontrolled hypertension (defined as diastolic blood pressure > 110 mmHg or systolic blood pressure > 180 mmHg during screening).\nWounds with severity greater than Grade 2 on the Wagner Scale\nLife-threatening ventricular arrhythmia - except if an ICD is implanted - or unstable angina - characterized by increasingly frequent episodes with modest exertion or at rest, worsening severity, and prolonged.\nST segment elevation myocardial infarction and/or TIA/CVA within six (6) months prior to enrollment.Patients with severe congestive heart failure (i.e. NYHA Stage IV)\nIn the opinion of the investigator, the patient is unsuitable for cellular therapy.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "40 Years",
      "MaximumAge": "81 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Cardiology PC",
            "LocationCity": "Birmingham",
            "LocationState": "Alabama",
            "LocationZip": "35211",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Duke University Medical Center",
            "LocationCity": "Durham",
            "LocationState": "North Carolina",
            "LocationZip": "27710",
            "LocationCountry": "United States"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000014652",
            "ConditionMeshTerm": "Vascular Diseases"
          },
          {
            "ConditionMeshId": "D000058729",
            "ConditionMeshTerm": "Peripheral Arterial Disease"
          },
          {
            "ConditionMeshId": "D000016491",
            "ConditionMeshTerm": "Peripheral Vascular Diseases"
          },
          {
            "ConditionMeshId": "D000007511",
            "ConditionMeshTerm": "Ischemia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          },
          {
            "ConditionAncestorId": "D000050197",
            "ConditionAncestorTerm": "Atherosclerosis"
          },
          {
            "ConditionAncestorId": "D000001161",
            "ConditionAncestorTerm": "Arteriosclerosis"
          },
          {
            "ConditionAncestorId": "D000001157",
            "ConditionAncestorTerm": "Arterial Occlusive Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafAsFound": "Vascular Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M28366",
            "ConditionBrowseLeafName": "Peripheral Arterial Disease",
            "ConditionBrowseLeafAsFound": "Peripheral Artery Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18046",
            "ConditionBrowseLeafName": "Peripheral Vascular Diseases",
            "ConditionBrowseLeafAsFound": "Peripheral Vascular Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M25341",
            "ConditionBrowseLeafName": "Atherosclerosis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3621",
            "ConditionBrowseLeafName": "Arteriosclerosis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3617",
            "ConditionBrowseLeafName": "Arterial Occlusive Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}